Gemmer Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-22
| Closed | – | – | 1409 |
|
|
2018
Q4 | $0 | Buy |
22
+1
| +5% | – | ﹤0.01% | 1382 |
|
|
2018
Q3 | $0 | Sell |
21
-600
| -97% | – | ﹤0.01% | 1425 |
|
|
2018
Q2 | $12K | Buy |
621
+1
| +0.2% | +$19 | ﹤0.01% | 609 |
|
|
2018
Q1 | $12K | Hold |
620
| – | – | ﹤0.01% | 604 |
|
|
2017
Q4 | $12K | Buy |
620
+601
| +3,163% | +$11.6K | ﹤0.01% | 626 |
|
|
2017
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 1274 |
|
|
2017
Q2 | $0 | Hold |
19
| – | – | ﹤0.01% | 1257 |
|
|
2017
Q1 | $0 | Buy |
+19
| New | – | ﹤0.01% | 1240 |
|
|
2016
Q4 | – | Sell |
-18
| Closed | – | – | 1226 |
|
|
2016
Q3 | $0 | Buy |
18
+1
| +6% | – | ﹤0.01% | 1243 |
|
|
2016
Q2 | $0 | Buy |
17
+1
| +6% | – | ﹤0.01% | 1262 |
|
|
2016
Q1 | $0 | Hold |
16
| – | – | ﹤0.01% | 1265 |
|
|
2015
Q4 | $0 | Hold |
16
| – | – | ﹤0.01% | 1280 |
|
|
2015
Q3 | $0 | Hold |
16
| – | – | ﹤0.01% | 1288 |
|
|
2015
Q2 | $0 | Hold |
16
| – | – | ﹤0.01% | 1335 |
|
|
2015
Q1 | $0 | Buy |
16
+1
| +7% | – | ﹤0.01% | 1379 |
|
|
2014
Q4 | $0 | Buy |
15
+1
| +7% | – | ﹤0.01% | 1432 |
|
|
2014
Q3 | $0 | Hold |
14
| – | – | ﹤0.01% | 1439 |
|
|
2014
Q2 | $0 | Hold |
14
| – | – | ﹤0.01% | 1454 |
|
|
2014
Q1 | $0 | Buy |
+14
| New | – | ﹤0.01% | 1413 |
|